Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Acta Ophthalmologica
|
March 30, 2024
Effect of chlorhexidine, povidone-iodine and betadine antiseptic eye drops on cultured human conjunctival goblet cell survival
Rubin Hadad, Anne Hedengran, Alex Barnils, et al.
Journal of Ophthalmology
|
August 25, 2021
Enhanced Physiological Stress Response in Patients with Normal Tension Glaucoma during Hypoxia
Line Marie Dalgaard, Jeppe Vibæk, Rupali Vohra, et al.
The British Journal of Ophthalmology
|
August 5, 2017
Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Panayiota Founti, Fotis Topouzis, Gábor Holló, et al.
Frontiers in Neuroscience
|
March 10, 2022
Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia
Mia Langbøl, Jens Rovelt, Arevak Saruhanian, et al.
Biomedicine Hub
|
October 7, 2021
Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro
Anne Hedengran, Xenia Begun, Olivia Müllertz, et al.
American Journal of Ophthalmology
|
May 20, 2022
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Anna-Sophie Thein, Anne Hedengran, Augusto Azuara-Blanco, et al.
Ophthalmic Research
|
December 20, 2011
Risk factors associated with progression in exfoliative glaucoma patients
Gábor Holló, Luciano Quaranta, Barbara Cvenkel, et al.
European Journal of Ophthalmology
|
June 15, 2010
Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?
Gábor Holló, Barbara Cvenkel, Miguel A Teus, et al.
The Ocular Surface
|
June 11, 2023
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
Miriam Kolko, Gus Gazzard, Christophe Baudouin, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Acta Ophthalmologica
|
March 30, 2024
Effect of chlorhexidine, povidone-iodine and betadine antiseptic eye drops on cultured human conjunctival goblet cell survival
Rubin Hadad, Anne Hedengran, Alex Barnils, et al.
Journal of Ophthalmology
|
August 25, 2021
Enhanced Physiological Stress Response in Patients with Normal Tension Glaucoma during Hypoxia
Line Marie Dalgaard, Jeppe Vibæk, Rupali Vohra, et al.
The British Journal of Ophthalmology
|
August 5, 2017
Prospective study of glaucoma referrals across Europe: are we using resources wisely?
Panayiota Founti, Fotis Topouzis, Gábor Holló, et al.
Frontiers in Neuroscience
|
March 10, 2022
Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?
Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia
Mia Langbøl, Jens Rovelt, Arevak Saruhanian, et al.
Biomedicine Hub
|
October 7, 2021
Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro
Anne Hedengran, Xenia Begun, Olivia Müllertz, et al.
American Journal of Ophthalmology
|
May 20, 2022
Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)-A Delphi Consensus Statement
Anna-Sophie Thein, Anne Hedengran, Augusto Azuara-Blanco, et al.
Ophthalmic Research
|
December 20, 2011
Risk factors associated with progression in exfoliative glaucoma patients
Gábor Holló, Luciano Quaranta, Barbara Cvenkel, et al.
European Journal of Ophthalmology
|
June 15, 2010
Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history?
Gábor Holló, Barbara Cvenkel, Miguel A Teus, et al.
The Ocular Surface
|
June 11, 2023
Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
Miriam Kolko, Gus Gazzard, Christophe Baudouin, et al.
Page
of 5